openPR Logo
Press release

World’s First Digital Ingestible Nanoparticle “Barcode” Makes Your Medicine “Smarter”

03-15-2018 12:27 PM CET | Health & Medicine

Press release from: nGageIT Digital Health Solutions

The 'Noz' NanoSmart health tool

The 'Noz' NanoSmart health tool

NanoSmart health tool by nGageIT makes taking medicine a digital experience.

Toronto, Canada March 13, 2018 - A new digital medicine startup company, nGageIT Digital Health Solutions, is making medicine smarter by developing the world’s first ingestible Digital Pharmaceutical Nano Encoding technology.

Patent pending "NanoSmart" digital encoding technology uses a mobile device that can passively detect the unique fingerprint of medications when ingested and remind patients of missed or late doses through their smartphone.

Called the Noz for short, the smart tool detects food grade safe nanoparticles or “barcodes” on tablets when ingested and the unique custom biosensor decodes these from the more than 2,500 substances in the human breath. Since each person’s breath is unique, like a fingerprint, it can be used as an identification method.

Future development of nGageIT’s biosensor technology includes the mobile detection of selected disease biomarkers from the breath, as well as as well as individualized data on how each person’s body deals with targeted medications.

Every time medication is ingested, the Noz’s biosensor identifies the tablet, the dose and other information, such as expiry date. This information is automatically mapped to the cloud and sent to the patient’s doctor and others in their health circle that they choose. This powerful data empowers physicians to easily and precisely customize therapy to the patient’s lifestyle, their behavior and their genes.

For pharmaceutical manufacturers, the technology can easily be applied to current inventory to minimize supply chain disruption.

Life Science companies and physicians gather this real life experience of patients from nGageIT’s custom patent-pending sensors to measure medication treatment effectiveness and optimize clinical outcomes. nGageIT Digital Health Solutions is currently evaluating strategic partnerships with major pharmaceutical manufacturers to commercialize its technology.

Says co-founder Dr Jennifer Murdoch, an expert in health systems, “nGageIT aims to improve wellness in the healthcare ecosystem and solve the $564 billion global problem of lost pharma revenue due to non-adherence and disengaged patients. We are focused on the $34 billion niche in Specialty High Value Pharmaceutical market as well as the diabetic market”.

“Low Medication Adherence is arguably the most significant problem in our health care eco-system, costing over $300 billion dollars in the USA alone and leading to over 125,000 premature deaths,” adds nGageIT’s Raj Reddy “this is an opportunity to truly tailor therapy to individual patients using digital medicine”.

With over 15 trillion doses of medications in the global supply chain and a substantially related number of disconnected patients - nGageIT aims to connect them all.

The NanoSmart oral encoding platform key features:

- NanoSmart turns any approved oral dosage form into a digital object
- A custom biosensor detects from the breath the digitally encoded nanoparticles ‘like an ingestible barcode’
- Food Grade Safe NanoSmart particles create unique detectable ingestible nanocodes for any oral medication
- No external sensors needed for patients to wear for detection – simply breathe
- Mobile detection device the “Noz” works through your smartphone
- A companion app provides information on dosage and automated reminders
- For further support patients can connect with practitioners through video or live chat
- NanoSmart encoding particles can be safely integrated into current oral dosage form coatings used by pharmaceutical manufacturers which minimizes supply chain disruption.

About nGageIT

nGageIT ( are pioneers in the field of digital medicine encoding and sensor technology. nGageIT is making medicine smarter to improve patient engagement, enrich insights and optimize therapeutic outcomes, resulting in lower overall system costs and improved health outcomes for populations.

For further information contact:

Dr Jennifer Murdoch
+1 650-262-1986 ext 502

nGageIT Digital Medicine
Toronto- 1 Yonge Street, Suite 1801
Toronto, Ontario M5E 1W7

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release World’s First Digital Ingestible Nanoparticle “Barcode” Makes Your Medicine “Smarter” here

News-ID: 978891 • Views: 432

More Releases from nGageIT Digital Health Solutions

Introducing AiroStotle: The Future of Digital Medicine is Here
Collaboration with MetroHealth hospitals of Cleveland, Ohio sees the world’s first deployment of nGageIT Digital Health’s novel breath-based NanoSensor technology for Digital Medicine. Cleveland, Ohio., February 8, 2019 – AiroStotle™ is a digital breath biomarker sensor, developed under nGageIT’s Airostotle™ Digital Biomarker program for early-stage detection and monitoring the recurrence of cancer. In a collaboration with MetroHealth hospitals of Cleveland, Ohio - advocates for teaching and research - clinical trials with
World’s First Connected Injector Non-Invasively Detects Insulin Below the Skin
Smart health tools by nGageIT allow diabetic insulin users and others to ‘Inject, Detect and Go’. Toronto, Canada March 10, 2018 - A revolutionary smart injection device is in development by a new digital medicine startup company, nGageIT Digital Health Solutions. The device safely and automatically detects insulin and other injectable medications after injection below the skin and connects to the cloud through your smartphone. Patients using injections like insulin can

More Releases for Nano

North America Nano PLC Market Growing at 15.8% CAGR to 2027 | By Type - Fixed Na …
North America Nano PLC Market Forecast to 2027 - COVID-19 Impact and Global Analysis" report added to ReportsWeb has covered and analyzed the potential of Global North America Nano PLC Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along
Nano UAV Global Information 2019
Press Release – 29 Jan 2019 Research and Development News -- . . Latest Update "Global Nano UAV Market Research Report 2019" with Industries Survey | Global Current Growth and Future. ' ' The global Nano UAV market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nano UAV volume and value at global level,
Nano Gas Sensor Market analysis report- with Leading players, Applications and M …
Nano Gas Sensor Market Worldwide Market Reports has announced the addition of the “Global Nano Gas Sensor Industry Market Research Report”, The report classifies the global Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Nano Gas Sensor Market provides market information about Top Manufacturers, Market segmentation, Types, Application and Regions. Powder Packing Machines Market also share Market capacity, Production, Revenue, Market
Nano Chemotherapy Market Nano Chemotherapy Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Nano Chemotherapeutics Mediations andndash; Solicitation to Nanomedicine 1.1 Overview 1.2 Nano Chemotherapeutics with Pharmaceutical Potential Significance of Nano Chemotherapeutics to overcome the Chemotherapy Limitations 2.1 Limitations of Conventional Chemotherapy 2.2 Nanotechnology in Cancer Targeting 2.2.1 Active Targeting 2.2.2 Passive Targeting 2.2.3 pH Dependent Drug Delivery Through Nanoparticles Role
ZOTAC Releases New ZBOX nano ID67 Series
Dubai, UAE – Jan. 14, 2014 – ZOTAC International, a global innovator and manufacturer of graphics cards, mainboards, mini-PCs and accessories, today releases the new ZBOX nano ID67 series with 4th Generation Intel Core technology. The new ZOTAC ZBOX nano ID67 series incorporates the latest Intel Core i3 4010U processor for great day-to-day performance and excellent energy efficiency. “Our engineers continue to boost performance of our ZBOX mini-PCs. The latest ZBOX
FIBEROPTIC NANO TEMPERATURE SENSOR AND NANO-KIT Fiber optic temperature sensors from different manufacturers typically use especially prepared fiberglass for temperature measurement. These fiber tips consist of gallium arsenide (GaAs) crystals. This type of sensor is very expensive to produce and mechanically sensitive to impact. The good news is: The fiber optic temperature sensors from Optocon AG are also available in a nano-powder version. Bound nano scaled GaAs powder adhesive, replaces the previous GaAs